FDA Investigator Claudia Mperez Kasmarski

Claudia Mperez Kasmarski has conducted inspections on 22 sites in 2 countries as of 08 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
08 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100002872
Countries of Inspections:
United States of America, Mexico
FDA Investigators that have inspected at least one site in common with Claudia Mperez Kasmarski:
Alan L Truong, Alan P Kurtzberg, Aliza Chalapong Asawesna, Amanda L Fyles, Amir Alavi, Ana P Pineda Zavaleta, Anderson, Andrea A Branche, Andrew Le, Andrew P Lin, Angele C Smith, Anh M Lac, Anita Narula, PhD, Anthony G Emerson, Arsen Karapetyan, Bichsa T Tran, Binh T Nguyen, Bryan A Galvez, Bush, Carla J Lundi, Carlos Chavez, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Cathleen A Carr Sharpe, Christopher D Washington, Christopher R Czajka, Cynthia F Kleppinger, MD, Darlene B Almogela, Darren S Brown, Deborah A Greco, Diane Cvan Leeuwen, Djamila Harouaka, Eileen A Liu, Erik M Slama, Esther B Gamallo Herrera, Evelyn Wong, Gam S Zamil, Gavin T Cua, German Rivera, Heriberto Negron Rivera, James A Barreto, Jeffrey M Watson, Jennifer M Gogley, Joey V Quitania, John A Gonzalez, John P Jorgensen, Jolanna A Norton, Judy C Nepsa, Kari M Johansen, Kathy Chiu, Kathy Kuo, Kelley, Kelvin Cheung, Kelvin X Sanders, Kenneth S Boehnen, Kham Phommachanh, Kim Lthomas Cruse, Lakecha N Lewis, Lance Mde Souza, MBA, Leonard H Lavi, Linda Thai, Lisa Shin, Lixia Cai, Marcus F Yambot, Marie K Kinkade, Marshalette O Edwards, Matthew J Johnson, Maxyne T Lam, Michael D Kawalek, Michael L Casner, Michael Shanks, MS, Miguel A Martinez Perez, Mihaly S Ligmond, Muna Algharibeh, Nathan E Hellman, Navneet Kaur, Nelly N Tran, Nicholas L Hunt, Patricia F Alberico, Paul A Bonneau, Peter E Baker, Phal K Chhun, Phillip L Toy, Rafael Nevarez Nieves, Raymond T Oji, Reba A Gates, Richmond K Yip, Rumany C Penn, PharmD, Sandra S Saniga, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah A Hassas, Scott N Lim, Sonia R Peterson, Stephanie A Slater, MS, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Thao T Kwan, Thomas W Gordon, Tracey T Duong, Truong Xuan Nguyen (Andy), Tuan A Nguyen, Uttaniti Limchumroon (Tom), Virgilio F Pacio, CSO, Walden H Lee, Wenzheng Wendy Zhang, William J Leonard, William V Millar, Yasamin Ameri, Yumi J Hiramine, Yvette E Guillermo, Zachary A Bogorad

Claudia Mperez Kasmarski's Documents

Publish Date Document Type Title
September, 2021 FDA 483 PYRAMID Laboratories, Inc. - Form 483, 2021-09-29
September, 2022 FDA 483 Defender SD Manufacturing LLC - Form 483, 2022-09-22
January, 2020 FDA 483 Nitto Avecia Pharma Services, Inc. - Form 483, 2020-01-24
September, 2021 FDA 483 Response PYRAMID Laboratories, Inc. - Form 483R, 2021-09-29
April, 2021 FDA 483 Clinical Resolution Laboratory, Inc. - Form 483, 2021-04-27
September, 2021 EIR PYRAMID Laboratories, Inc. - EIR, 2021-09-29
February, 2020 FDA 483 Soaptronic LLC. - Form 483, 2020-02-14
July, 2021 FDA 483 NuSil Technology LLC - Form 483, 2021-07-16
December, 2022 FDA 483 FNC MEDICAL CORPORATION - Form 483, 2022-12-09
February, 2023 FDA 483 ACTA Laboratories Inc - Form 483, 2023-02-13
December, 2021 FDA 483 Genlabs Corporation - Form 483, 2021-12-09
April, 2023 FDA 483 Response RADIANCE BEAUTY & WELLNESS INC. - Form 483R, 2023-05-18
April, 2023 FDA 483 RADIANCE BEAUTY & WELLNESS INC. - Form 483, 2023-04-28
August, 2022 FDA 483 Chemcor Chemical Corporation - Form 483, 2022-08-31
January, 2020 EIR Nitto Avecia Pharma Services, Inc. - EIR, 2020-01-24
December, 2023 FDA 483 Innovation Specialties, Inc. - Form 483, 2023-12-08
April, 2024 FDA 483 Bausch Health Americas, Inc. - Form 483, 2024-04-12
November, 2022 FDA 483 COSMOCEUTICAL RESEARCH CENTER INC - Form 483, 2022-11-04
March, 2022 FDA 483 Green Wave Analytical, LLC - Form 483, 2022-03-07
April, 2022 FDA 483 O.C.C.S. Inc. - Form 483, 2022-04-29
June, 2024 FDA 483 Pharmadepot Labs, LLC - Form 483, 2024-06-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more